TY - JOUR
T1 - ATP sensitive potassium channels are involved in adenosine A2 receptor mediated coronary vasodilatation in the dog
AU - Akatsuka, Yutaka
AU - Egashira, Kensuke
AU - Katsuda, Yousuke
AU - Narishige, Takahiro
AU - Ueno, Hideki
AU - Shimokawa, Hiroaki
AU - Takeshita, Akira
N1 - Funding Information:
The authors are grateful to M Mizokami for her technical assistance. This study was supported in part by grants-in-aid for Scientific Research Nos 05857085 and 05670619 from the Ministry of Education, Science and Culture, Tokyo, Japan; by a Research Development Award from the Japan Heart Foundation; by a Japan Cardiovascular Foundation Grant, Osaka, Japan; and by a Research Grant from the Naito Memorial Foundation, Tokyo, Japan.
PY - 1994/6
Y1 - 1994/6
N2 - Objective: The aim was to determine a role of ATP sensitive potassium (KATP) channels in adenosine A2 receptor mediated coronary vasodilatation in anaesthetised dogs in vivo. Methods: Coronary blood flow in the left circumflex coronary artery, aortic pressure, and left ventricular pressure were measured during intracoronary infusions of the drugs into the left circumflex artery. Results: A non-selective A2 receptor agonist NECA (5'-N-ethylcarboxamidoadenosine) at 10-10-10-8 mol·min-1 before and after an A, receptor antagonist DPCPX (8-cyclopentyl-l,3-dipropylxanthine) increased coronary blood flow in a dose dependent manner, without affecting other haemodynamic variables. Glibenclamide at 10 μg·kg-1·min-1, which did not alter baseline haemodynamic variables, markedly inhibited the increases in coronary blood flow caused by NECA alone and after DPCPX (p<0.01). A non-selective adenosine receptor antagonist 8-phenyltheophylline abolished the NECA induced increases in coronary blood flow after DPCPX. These results suggest that A2 receptor mediated coronary vasodilatation was mediated largely by opening of KATP channels. Glibenclamide did not alter the increase in coronary blood flow evoked by forskolin or acetylcholine, suggesting that KATP channels may not be involved in coronary vasodilatation induced by activation of adenylate cyclase or guanylate cyclase. Furthermore, DPCPX increased basal coronary blood flow, which was blocked by 8-phenyltheophylline and by glibenclamide, suggesting that it may have unmasked A2 receptor mediated coronary vasodilatation by inhibiting the A1 receptor mediated vasoconstricting action of endogenous adenosine. Conclusions: Opening of KATP channels may be involved importantly in adenosine A2 receptor mediated coronary vasodilatation in canine hearts.Cardiovascular Research 1994:28:906-911.
AB - Objective: The aim was to determine a role of ATP sensitive potassium (KATP) channels in adenosine A2 receptor mediated coronary vasodilatation in anaesthetised dogs in vivo. Methods: Coronary blood flow in the left circumflex coronary artery, aortic pressure, and left ventricular pressure were measured during intracoronary infusions of the drugs into the left circumflex artery. Results: A non-selective A2 receptor agonist NECA (5'-N-ethylcarboxamidoadenosine) at 10-10-10-8 mol·min-1 before and after an A, receptor antagonist DPCPX (8-cyclopentyl-l,3-dipropylxanthine) increased coronary blood flow in a dose dependent manner, without affecting other haemodynamic variables. Glibenclamide at 10 μg·kg-1·min-1, which did not alter baseline haemodynamic variables, markedly inhibited the increases in coronary blood flow caused by NECA alone and after DPCPX (p<0.01). A non-selective adenosine receptor antagonist 8-phenyltheophylline abolished the NECA induced increases in coronary blood flow after DPCPX. These results suggest that A2 receptor mediated coronary vasodilatation was mediated largely by opening of KATP channels. Glibenclamide did not alter the increase in coronary blood flow evoked by forskolin or acetylcholine, suggesting that KATP channels may not be involved in coronary vasodilatation induced by activation of adenylate cyclase or guanylate cyclase. Furthermore, DPCPX increased basal coronary blood flow, which was blocked by 8-phenyltheophylline and by glibenclamide, suggesting that it may have unmasked A2 receptor mediated coronary vasodilatation by inhibiting the A1 receptor mediated vasoconstricting action of endogenous adenosine. Conclusions: Opening of KATP channels may be involved importantly in adenosine A2 receptor mediated coronary vasodilatation in canine hearts.Cardiovascular Research 1994:28:906-911.
KW - Adenosine
KW - Coronary circulation
KW - Glibenclamide
KW - Potassium channels
UR - http://www.scopus.com/inward/record.url?scp=85047677008&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85047677008&partnerID=8YFLogxK
U2 - 10.1093/cvr/28.6.906
DO - 10.1093/cvr/28.6.906
M3 - Article
C2 - 7923297
AN - SCOPUS:85047677008
SN - 0008-6363
VL - 28
SP - 906
EP - 911
JO - Cardiovascular Research
JF - Cardiovascular Research
IS - 6
ER -